Jan 13, 2022 / 02:45PM GMT
Mallika Prasad -
Good morning, and thank you for joining us today. My name is Mallika, and I'm an associate in JPMorgan's Healthcare Group. (Operator Instructions)
With that, I'm pleased to introduce you to Peter Greenleaf, CEO of Aurinia Pharmaceuticals. I know that he is very excited to tell you about his story, so we'll turn it over to Peter.
Peter S. Greenleaf - Aurinia Pharmaceuticals Inc. - President, CEO & Director
Good morning, Mallika, and good morning, everyone. Thanks for joining the call, and thank you to everyone at JPMorgan for having us as part of the conference today. Well, I know it's late in the game, we're Thursday, and this all kind of kicked off on Monday or over the weekend. So I know as investors, you've been I'm sure, going through many presentations and individual one-on-ones. Two things before we get started off here.
One is just logistically, I'm not sharing my screen. So there is a slide deck associated with the presentation. So what I'll try to do is, as I move from a slide is at least call out where I am within the
Aurinia Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers